Literature DB >> 4115002

Structural changes in the early stages of Duchenne muscular dystrophy.

W G Bradley, P Hudgson, P F Larson, T A Papapetropoulos, M Jenkison.   

Abstract

The finding of a relative absence of degeneration and regeneration in a muscle biopsy taken at 2½ weeks of age from a boy who later showed the florid pathological changes of preclinical Duchenne muscular dystrophy prompted a review of muscle biopsies taken from boys in the preclinical and early clinical stages of this disease. Only one other biopsy obtained in the first year of life was available. In this, taken at 2 months, there were active changes present. These findings suggest that biopsies taken to detect preclinical cases should not be performed at less than 2 months of age, and raise the possibility of the existence of a stage in Duchenne muscular dystrophy before active degeneration when the muscle shows little or no change on light microscopy.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4115002      PMCID: PMC494103          DOI: 10.1136/jnnp.35.4.451

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  4 in total

1.  Serum enzymes in muscular dystrophy and certain other muscular and neuromuscular diseases. I. Serum glutamic oxalacetic transaminase.

Authors:  C M PEARSON
Journal:  N Engl J Med       Date:  1957-06-06       Impact factor: 91.245

2.  Histopathological features of muscle in the preclinical stages of muscular dystrophy.

Authors:  C M PEARSON
Journal:  Brain       Date:  1962-03       Impact factor: 13.501

3.  Pre-clinical muscular dystrophy: histopathological changes observed on muscle biopsy.

Authors:  P Hudgson; G W Pearce; J N Walton
Journal:  Brain       Date:  1967-09       Impact factor: 13.501

4.  [Enzyme activity determination in progressive muscular dystrophy. IV. Serum enzymatic kinetics in the preclinical stage of the Duchenne type during the 1st 2 years of life].

Authors:  H Heyck; G Laudahn; P M Carsten
Journal:  Klin Wochenschr       Date:  1966-06-15
  4 in total
  9 in total

1.  Follistatin gene delivery enhances muscle growth and strength in nonhuman primates.

Authors:  Janaiah Kota; Chalonda R Handy; Amanda M Haidet; Chrystal L Montgomery; Amy Eagle; Louise R Rodino-Klapac; Danielle Tucker; Christopher J Shilling; Walter R Therlfall; Christopher M Walker; Steven E Weisbrode; Paul M L Janssen; K Reed Clark; Zarife Sahenk; Jerry R Mendell; Brian K Kaspar
Journal:  Sci Transl Med       Date:  2009-11-11       Impact factor: 17.956

2.  Muscle nuclear changes in fetuses at risk for Duchenne muscular dystrophy.

Authors:  D Vassilopoulos; A E Emery
Journal:  J Med Genet       Date:  1977-02       Impact factor: 6.318

3.  Hyperreactive (hyaline, opaque, dark) muscle fibers in Duchenne dystrophy. A biopsy study of 16 dystrophy and 205 other neuronmuscular disease cases and controls.

Authors:  K Boxler; F Jerusalem
Journal:  J Neurol       Date:  1978-09-12       Impact factor: 4.849

4.  Teaching monograph: pathology of skeletal muscle diseases.

Authors:  U U DeGirolami; T W Smith
Journal:  Am J Pathol       Date:  1982-05       Impact factor: 4.307

5.  Segmental fibre breakdown and defects of the plasmalemma in diseased human muscles.

Authors:  H Schmalbruch
Journal:  Acta Neuropathol       Date:  1975-12-08       Impact factor: 17.088

6.  Analysis of gene expression differences between utrophin/dystrophin-deficient vs mdx skeletal muscles reveals a specific upregulation of slow muscle genes in limb muscles.

Authors:  Patrick E Baker; Jessica A Kearney; Bendi Gong; Anita P Merriam; Donald E Kuhn; John D Porter; Jill A Rafael-Fortney
Journal:  Neurogenetics       Date:  2006-03-09       Impact factor: 2.660

7.  Myogenesis modelled by human pluripotent stem cells: a multi-omic study of Duchenne myopathy early onset.

Authors:  Virginie Mournetas; Emmanuelle Massouridès; Jean-Baptiste Dupont; Etienne Kornobis; Hélène Polvèche; Margot Jarrige; Alan R L Dorval; Maxime R F Gosselin; Antigoni Manousopoulou; Spiros D Garbis; Dariusz C Górecki; Christian Pinset
Journal:  J Cachexia Sarcopenia Muscle       Date:  2021-02-14       Impact factor: 12.910

8.  beta-Lactamase-producing anaerobes.

Authors:  S Reilly; A T Willis
Journal:  Lancet       Date:  1980-11-01       Impact factor: 79.321

Review 9.  Changes in Myonuclear Number During Postnatal Growth - Implications for AAV Gene Therapy for Muscular Dystrophy.

Authors:  Jennifer Morgan; Francesco Muntoni
Journal:  J Neuromuscul Dis       Date:  2021
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.